Two batches of birth control pills recalled over reduced effectiveness and pregnancy risk

Lupin Pharmaceuticals recalled two batches of Tydemy birth control pills distributed from June 2022 to May 2023.
The FDA warned the recalled pills may have insufficient levels of ingredients, impacting effectiveness.
Patients are advised to continue taking Tydemy but seek alternative contraceptive options from their doctor.
No adverse events related to the recalled batches have been reported.
The recall comes amid expanded access to birth control, including the first over-the-counter pill approved by the FDA.